CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: The small-bowel PCI score as a predictor of survival

BACKGROUND: Combining cytoreductive surgery (CRS) with Hyperthermic IntraPeritoneal Chemotherapy (HIPEC) can benefit patients with peritoneal metastasis from colorectal cancer. The present study evaluates the small bowel subset of the Peritoneal Cancer Index (Small-Bowel-PCI score (SB-PCI), min-max...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiliotis, John, Kalles, Vasileios, Kyriazanos, Ioannis, Terra, Alexios, Prodromidou, Anastasia, Raptis, Apostolos, Kopanakis, Nikolaos, Christopoulou, Athina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881666/
https://www.ncbi.nlm.nih.gov/pubmed/31799372
http://dx.doi.org/10.1515/pp-2019-0018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881666/
https://www.ncbi.nlm.nih.gov/pubmed/31799372
http://dx.doi.org/10.1515/pp-2019-0018

Ejemplares similares